Download - Fadoi

Giornale Italiano
di Medicina Interna
2. Hirsch AT, Criqui MH, Treat-Jacobsen D, et al.
Peripheral arterial disease detection, awareness and
treatment in primary care. JAMA 2001;286:1317-
1324.
3. Bashir R, Cooper CJ. Evaluation and medical treatment
of peripheral arterial disease. Curr Opin Cardiol
2003;18(6):436-443.
4. Jude EB, Oyibo SO, Chalmers N, et al. Peripheral
arterial disease in diabetic and nondiabetic patients:
a comparison of severity and outcome. Diabetes
Care 2001;24(8):1433-1437.
5. Aronow WS, Ahn C. Elderly diabetics with peripheral
arterial disease and no coronary artery disease
have a higher incidence of new coronary events
than elderly nondiabetics with peripheral arterial
disease and prior myocardial infarction treated with
statins and with no lipid-lowering drug. J Gerontol
A Biol Sci Med Sci 2003;58(6):573-575.
6. OHare AM, Glidden DV, Fox CS, et al. High prevalence
of peripheral arterial disease in persons with
renal insufficiency: results from the national health
and nutrition examination survey 1999-2000. Circulation
2004;109(3):320-323.
7. Meijer WT, Hoes AW, Rutgers D, et al. Peripheral
arterial disease in the elderly: the Rotterdam Study.
Arterioscler Thromb Vasc Biol 1998;18:185-192.
8. Murabito JM, Evans JC, Nieto K, et al. Prevalence
and clinical correlates of peripheral arterial disease
in the Framingham Offspring Study. Am Heart J
2002;143(6):961-965
9. Diehm C, Schuster A, Allenberg JR, et al. High prevalence
of peripheral arterial disease and co-morbidity
in 6880 primary care patients: cross-sectional
study. Atherosclerosis 2004;172(1):95-105.
10. Strano A, Novo S, Avellone G, et al. Hypertension
and other risk factors in peripheral arterial disease.
Clin Exp Hypertens 1993;15 (Suppl 1):71-89.
11. McKenna M, Wolfson S, Kuller L. The ratio of ankle
and arm arterial pressure as an independent predictor
of mortality. Atherosclerosis 1991;87:119-128.
12. Belch JJ, Topol EJ, Agnelli GC, et al. For the Prevention
of Atherothrombotic Disease Network.
Critical issues in peripheral arterial disease. Detection
and Management. A call to action. Arch Intern
Med 2003;163:884-892.
13. Bismuth J, Klitford L, Sillesena H. The lack of cardiovascular
risk factor management in patients with
critical limb ischaemia. Eur J Vasc Endovasc Surg
2001;21:143-146.
14. Criqui MH, Langer RD, Fronek A, et al. Mortality
over a period of ten years in patients with peripheral
arterial disease. N Engl J Med 1992;326:381-386.
15. Bell RE, Taylor PR. Screening for peripheral vascular
disease: why don’t we do it? Int J Clin Pract
2002;56:412-413.
16. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis
as a reflection of a systemic process:
implications for concomitant coronary and carotid
disease. Semin Vasc Surg 1999;12:118-122.
17. Cotter G, Cannon CP, McCabe CH, et al. Prior
peripheral arterial disease and cerebrovascular
disease are independent predictors of adverse outcome
in patients with acute coronary syndromes:
90
2005;4:84-91
are we doing enough? Results from the Orbofiban
in Patients with Unstable Coronary Syndromes-
Thrombolysis In Myocardial Infarction (OPUS-TIMI)
16 study. Am Heart J 2003;145(4):622-627.
18. Bergstrand L, Olsson AG, Erikson U, et al. The relation
of coronary and peripheral arterial disease to
the severity of femoral atherosclerosis in hypercholesterolaemia.
J Intern Med 1994;236(4):367-375.
19. Hiatt WR. Medical treatment of peripheral arterial
disease and claudication. N Engl J Med 2001;344:
1608-1621.
20. McDermont MM, Mehta S, Liun K, et al. Leg symptoms,
the ankle-brachial index and walking ability
in patients with peripheral arterial disease. J Gen
Intern Med 1999;14:173-181.
21. Imparato Am, Kim GE, Davidson T, et al. Intermittent
claudication: its natural course. Surgery 1975;
78:795-799.
22. Davey Smith G, Shipley MJ, Rose G. Intermittent
claudication, heart disease risk factor and mortality.
The Whitehall Study. Circulation 1990;82:1925.
23. Hirsch AT, Gotto AM Jr. Undertreatment of dyslipidemia
in peripheral arterial disease and other highrisk
populations: an opportunity for cardiovascular
disease reduction. Vasc Med 2002;7(4):323-331.
24. McDermott MM, Mandapat AL, Moates A, et al.
Knowledge and attitudes regarding cardiovascular
disease risk and prevention in patients with coronary
or peripheral arterial disease. Arch Intern
Med 2003;163(18):2157-2162.
25. Newman AB, Sutton-Tyrell K, Vogt MT, et al. Morbidity
and mortality in hypertensive adults with
low ankle-arm blood pressure index. JAMA 1993;
270:487-489.
26. DaSilva A, Widmer LK, Ziegler HW, et al. The Basle
longitudinal study; report on the relation of initial
glucose level to baseline ECG abnormalities,
peripheral artery disease, and subsequent mortality.
J Chron Dis 1979;32:797-803.
27. Bloor K. Natural history of arteriosclerosis of the
lower extremities. Ann R Coll Surg Engl 1961;28:36-
51.
28. TransAtlantic Inter-Society Consensus (TASC). Management
of peripheral arterial disease. J Vasc Surg
2000;1(Suppl):1-296.
29. Burns P, Gough S, Bradbury WA. Management of
peripheral arterial disease in primary care. BMJ
2003;326:584-588.
30. The ICAI Group (gruppo di studio dell’ischemia cronica
critica degli arti inferiori). Long-term mortality
and its predictors in patients with critical leg
ischemia. Euro J Vasc Endovasc Surg 1997;14:91-
95.
31. Juergens JL, Barker NW, Hines EA. Arteriosclerosis
obliterans: review of 520 cases with special reference
to pathogenic and prognostic factors. Circulation
1960;21:188-195.
32. Furburg CD, Adams HP, Applegate WB, et al. Effect
of lovastatin on early atherosclerosis and cardiovascular
events. Circulation 1994;90:1679-1687.
33. Crouse JR, Byington PB, Bond MG et al. Pravastatin,
lipids and atherosclerosis in the carotid arteries
(PLAC-II). Am J Cardiol 1995;75:455-459.